Allows pharmaceutical companies to communicate off-label treatment uses to health care professionals
| Sponsor: |
Neely, Jim (008) |
| Proposed Effective Date: |
8/28/2018 |
| LR Number: |
4103H.02C |
| Last Action: |
04/26/2018 - Reported Do Pass (H) |
| Bill String: |
HCS HB 1524 |
| Next House Hearing: |
Hearing not scheduled |
| Calendar: |
Bill currently not on a House calendar |